Latest / The Dales Report | Trade to Black
Avicanna Executive Team On U.S. Rescheduling Opportunity
In our latest Trade To Black podcast presented by Flowhub, host Shadd Dales sits down with Avicanna (TSX:AVCN / OTCQX:AVCNF) CEO Aras Azadian and Dr. Karolina Urban, Executive Vice President of Scientific and Medical Affairs, to talk about what U.S. cannabis rescheduling could mean for cannabinoid-based medicine.With the DOJ and DEA now moving certain cannabinoid products into a Schedule III framework, the big question becomes simple:Which companies are actually ready for a more pharmaceutical, evidence-based model?Avicanna (TSX:AVCN / OTCQX:AVCNF) has spent years building around clinical…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.